Target intelligence / Profile preview

Integrin subunit alpha 7 (ITGA7)

Target
ITGA7
Molecular classification
Integrin
01

Overview

Integrin subunit alpha 7 (ITGA7) is a transmembrane protein that forms a heterodimer with beta-1 integrin, serving as the primary laminin receptor in skeletal myoblasts and adult myofibers. It mediates critical cell-matrix interactions by binding laminins such as laminin-1, -2, and -4, and is highly expressed in skeletal, cardiac, and smooth muscle cells, where it localizes to Z-discs and costameres. This integrin plays essential roles in myoblast adhesion, migration, and differentiation during myogenesis, as well as in maintaining myofiber cytoarchitecture, anchorage, viability, and functional integrity. Knockout studies in mice reveal muscular dystrophy-like phenotypes with disrupted myotendinous junctions, fiber size variation, necrosis, and elevated creatine kinase, underscoring its importance in muscle stability, potentially overlapping with sarcoglycan and dystrophin functions. Mutations in ITGA7 cause congenital myopathies, severe congenital fiber type disproportion, and left ventricular non-compaction cardiomyopathy, while altered expression occurs in Duchenne and Becker muscular dystrophies. AAV-mediated overexpression of ITGA7 in DMD mouse models shows protective effects against muscle degeneration, suggesting therapeutic potential, though no approved drugs currently target it.

Other names
Alpha-7 integrinIntegrin alpha-7
02

Biological functions

Cell-matrix adhesionMyogenesisMuscle differentiationMuscle maintenance
03

Disease associations

Congenital myopathyMuscular dystrophyNoncompaction cardiomyopathy

Beyond the preview

Go deeper on Integrin subunit alpha 7 (ITGA7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin subunit alpha 7 (ITGA7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call